{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,27]],"date-time":"2026-05-27T15:25:05Z","timestamp":1779895505044,"version":"3.53.1"},"reference-count":19,"publisher":"Public Library of Science (PLoS)","issue":"8","license":[{"start":{"date-parts":[[2019,8,26]],"date-time":"2019-08-26T00:00:00Z","timestamp":1566777600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0221598","type":"journal-article","created":{"date-parts":[[2019,8,26]],"date-time":"2019-08-26T17:28:13Z","timestamp":1566840493000},"page":"e0221598","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":11,"title":["Choice of the initial antiretroviral treatment for HIV-positive individuals in the era of integrase inhibitors"],"prefix":"10.1371","volume":"14","author":[{"given":"Bel\u00e9n","family":"Alejos","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7016-716X","authenticated-orcid":true,"given":"In\u00e9s","family":"Su\u00e1rez-Garc\u00eda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Otilia","family":"Bisbal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9 Antonio","family":"Iribarren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V\u00edctor","family":"Asensi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miguel","family":"G\u00f3rgolas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberto","family":"Muga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Santiago","family":"Moreno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Inma","family":"Jarr\u00edn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"CoRIS cohort","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2019,8,26]]},"reference":[{"key":"pone.0221598.ref001","unstructured":"Panel de expertos de Gesida y Plan Nacional sobre el SIDA (2017) Documento de consenso de GeSIDA\/Plan Nacional sobre el Sida respecto al tratamiento antirretroviral en adultos infectados por el virus de la inmunodeficiencia humana (Actualizaci\u00f3n enero 2017)."},{"key":"pone.0221598.ref002","unstructured":"European AIDS Clinical Society (2017) EACS Guidelines. Version 9.0. October 2017."},{"key":"pone.0221598.ref003","unstructured":"Pannel on Antiretroviral Guidelines for Adults and Adolescents Guidelines for the Use of Antiretroviral Agents in Adults and Adolescents Living with HIV (update October 25, 2018). Department of Health and Human Services."},{"key":"pone.0221598.ref004","unstructured":"GeSIDA\/Plan Nacional sobre el SIDA Documento de consenso de GeSIDA\/Plan Nacional sobre el SIDA respecto al tratamiento antirretroviral en adultos infectados por del virus de la inmunodeficiencia humana (actualizaci\u00f3n Enero 2018)."},{"key":"pone.0221598.ref005","first-page":"93","article-title":"[Initial antiretroviral treatment in human immunodeficiency virus-infected patients in Spain: Decisions made in relation to particular immunovirological characteristics (PERFIL-es study)]","volume":"32","author":"P Viciana","year":"2014","journal-title":"Enferm Infecc Microbiol Clin"},{"key":"pone.0221598.ref006","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/j.jinf.2015.03.005","article-title":"Factors influencing combination antiretroviral therapy choice: Do doctors really know best?","volume":"71","author":"M Hata","year":"2015","journal-title":"J Infect"},{"key":"pone.0221598.ref007","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1001\/archinternmed.2012.3216","article-title":"Choice of Initial Combination Antiretroviral Therapy in Individuals With HIV Infection: Determinants and Outcomes","volume":"172","author":"L Elzi","year":"2012","journal-title":"Arch Intern Med"},{"key":"pone.0221598.ref008","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1080\/09540121.2016.1173640","article-title":"Sociodemographic and clinical factors associated with the preference between NNRTIs and PIs for the initial treatment of HIV infection: Perfil-es study","volume":"28","author":"P Viciana","year":"2016","journal-title":"AIDS Care"},{"key":"pone.0221598.ref009","first-page":"796","article-title":"[Choice of initial regimen for antiretroviral-naive HIV patients: Analysis of motivation]","volume":"37","author":"E Rouveix","year":"2016","journal-title":"Rev Med Interne"},{"key":"pone.0221598.ref010","first-page":"23","article-title":"[Spanish cohort of naive HIV-infected patients (CoRIS): rationale, organization and initial results]","volume":"25","author":"AM Caro-Murillo","year":"2007","journal-title":"Enferm Infecc Microbiol Clin"},{"key":"pone.0221598.ref011","first-page":"645","article-title":"[The Cohort of the Spanish HIV Research Network (CoRIS) and its associated biobank; organizational issues, main findings and losses to follow-up]","volume":"29","author":"P Sobrino-Vegas","year":"2011","journal-title":"Enferm Infecc Microbiol Clin"},{"issue":"446","key":"pone.0221598.ref012","first-page":"e441","article-title":"[GeSIDA\/National AIDS Plan: Consensus document on antiretroviral therapy in adults infected by the human immunodeficiency virus (Updated January 2014)]","volume":"32","year":"2014","journal-title":"Enferm Infecc Microbiol Clin"},{"issue":"543","key":"pone.0221598.ref013","first-page":"e541","article-title":"[GESIDA\/National AIDS Plan: Consensus document on antiretroviral therapy in adults infected by the human immunodeficiency virus (Updated January 2015)]","volume":"33","year":"2015","journal-title":"Enferm Infecc Microbiol Clin"},{"key":"pone.0221598.ref014","unstructured":"Panel de expertos de Gesida y Plan Nacional sobre el SIDA Documento de consenso de GeSIDA\/Plan Nacional sobre el Sida respecto al tratamiento antirretroviral en adultos infectados por el virus de la inmunodeficiencia humana (Actualizaci\u00f3n enero 2016)."},{"key":"pone.0221598.ref015","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1310\/hct1401-10","article-title":"Prevalence of primary resistance mutations to integrase inhibitors in treatment-naive and -experienced patients infected with B and non-B HIV-1 variants","volume":"14","author":"C Gutierrez","year":"2013","journal-title":"HIV Clin Trials"},{"key":"pone.0221598.ref016","doi-asserted-by":"crossref","first-page":"2885","DOI":"10.1093\/jac\/dkv202","article-title":"Primary resistance to integrase strand-transfer inhibitors in Europe","volume":"70","author":"M Casadella","year":"2015","journal-title":"J Antimicrob Chemother"},{"key":"pone.0221598.ref017","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1001\/archinternmed.2012.3644","article-title":"An Abundance of Choices: Comment on \"Choice of Initial Combination Antiretroviral Therapy in Individuals With HIV Infection: Determinants and Outcomes","volume":"172","author":"DR Kuritzkes","year":"2012","journal-title":"Arch Intern Med"},{"key":"pone.0221598.ref018","article-title":"Cost limitations and restricted access to antiretroviral drugs as potential barriers for compliance to HIV treatment guidelines in the CoRIS cohort. X Conference of the Spanish AIDS Study Group (GeSIDA)","author":"I Su\u00e1rez-Garc\u00eda","year":"2018","journal-title":"Madrid"},{"key":"pone.0221598.ref019","article-title":"Reasons for noncompliance with the national guidelines for initial antiretroviral therapy of HIV-infected patients in Spain, 2010\u20132015","author":"I Suarez-Garcia","year":"2019","journal-title":"Enferm Infecc Microbiol Clin"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0221598","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,9]],"date-time":"2020-05-09T05:06:21Z","timestamp":1589000781000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0221598"}},"subtitle":[],"editor":[{"given":"Robert","family":"G\u00fcerri-Fern\u00e1ndez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2019,8,26]]},"references-count":19,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2019,8,26]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0221598","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,8,26]]}}}